COVID-19: Zydus Cadila gets DCGI nod for phase-III clinical trials
<p>Ahmedabad based Zydus Cadila Pharmaceuticals has announced that the company has received an approval from the Drugs Controller General of India -DCGI to begin the phase-III clinical trials with its biological therapy Pegylated Interferon alpha-2b (PegiHep) in Covid-19 patients. PegiHep is an approved drug and is being re-purposed for the treatment of Covid-19. According to […]</p>
/connect-gujarat-english/media/post_banners/wp-content/uploads/2020/11/freepressjournal_import_2017_09_Mumbai-western-railway.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2020/12/8-4.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2020/11/1-19.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2020/11/14-1.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2020/11/6-5.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2020/11/3.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2020/10/8-19-scaled.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2020/10/uu-e1603607289544.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2020/10/pjimage-26.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2020/10/IMG-20201007-WA0036.jpg)